Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bunjes

Showing results (41-50 of 101) with videos related to

Pageof 11
Sort By:
Blood|August 15, 1995
Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphomaB Hertenstein, B Wagner, D Bunjes, et al.
Deutsche Medizinische Wochenschrift (1946)|January 8, 1988
[Bone marrow transplantation as therapy in chronic myeloid leukemia]T Schmeiser, R Arnold, M Wiesneth, et al.
European Journal of Haematology|August 4, 1998
Chronic myeloid leukemia in accelerated phase: treatment results with conventional chemotherapy and allogeneic bone marrow transplantation in 96 patientsM Griesshammer, R Arnold, M Bangerter, et al.
British Journal of Haematology|November 1, 1986
Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantationW Heit, D Bunjes, M Wiesneth, et al.
Bone Marrow Transplantation|September 1, 1993
Graft rejection by a population of primed CDw52- host T cells after in vivo/ex vivo T-depleted bone marrow transplantationD Bunjes, M Theobald, M Wiesneth, et al.
Klinische Wochenschrift|October 15, 1987
Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantationT Schmeiser, W Heit, R Arnold, et al.
Genes, Chromosomes & Cancer|March 10, 2001
Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCRJ Krauter, W Hoellge, M P Wattjes, et al.
Bone Marrow Transplantation|February 6, 2007
CMV monitoring using blood cells and plasma: a comparison of apples with oranges?L von Müller, J Hinz, M Bommer, et al.
Nuklearmedizin. Nuclear Medicine|May 20, 2006
Dosimetry with (188)Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.iG Glatting, T Kull, N M Blumstein, et al.
Bone Marrow Transplantation|January 1, 1991
Kinetics of relapse of leukemia after bone marrow transplantation: cytogenetic follow up of patients with chronic myelogenous leukemiaB Heinze, R Arnold, E Kratt, et al.
Pageof 11

Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Blood|August 15, 1995
Emergence of CD52-, phosphatidylinositolglycan-anchor-deficient T lymphocytes after in vivo application of Campath-1H for refractory B-cell non-Hodgkin lymphomaB Hertenstein, B Wagner, D Bunjes, et al.
Deutsche Medizinische Wochenschrift (1946)|January 8, 1988
[Bone marrow transplantation as therapy in chronic myeloid leukemia]T Schmeiser, R Arnold, M Wiesneth, et al.
European Journal of Haematology|August 4, 1998
Chronic myeloid leukemia in accelerated phase: treatment results with conventional chemotherapy and allogeneic bone marrow transplantation in 96 patientsM Griesshammer, R Arnold, M Bangerter, et al.
British Journal of Haematology|November 1, 1986
Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantationW Heit, D Bunjes, M Wiesneth, et al.
Bone Marrow Transplantation|September 1, 1993
Graft rejection by a population of primed CDw52- host T cells after in vivo/ex vivo T-depleted bone marrow transplantationD Bunjes, M Theobald, M Wiesneth, et al.
Klinische Wochenschrift|October 15, 1987
Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantationT Schmeiser, W Heit, R Arnold, et al.
Genes, Chromosomes & Cancer|March 10, 2001
Detection and quantification of CBFB/MYH11 fusion transcripts in patients with inv(16)-positive acute myeloblastic leukemia by real-time RT-PCRJ Krauter, W Hoellge, M P Wattjes, et al.
Bone Marrow Transplantation|February 6, 2007
CMV monitoring using blood cells and plasma: a comparison of apples with oranges?L von Müller, J Hinz, M Bommer, et al.
Nuklearmedizin. Nuclear Medicine|May 20, 2006
Dosimetry with (188)Re-labelled monoclonal anti-CD66 antibodies. A simplified approach based on a single measurement 3 h p.iG Glatting, T Kull, N M Blumstein, et al.
Bone Marrow Transplantation|January 1, 1991
Kinetics of relapse of leukemia after bone marrow transplantation: cytogenetic follow up of patients with chronic myelogenous leukemiaB Heinze, R Arnold, E Kratt, et al.
Pageof 11